Evidence map›Paper›PMID 24618595›Full record

ArticleScientific reports2014

Partial somatic to stem cell transformations induced by cell-permeable reprogramming factors.

Junghee Lim, Junghee Kim, Jinsun Kang, Daewoong Jo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Cell-PermeableInternational journal of molecular sciences · 2021
    Article
  4. Cellular Reprogramming Using Protein and Cell-Penetrating Peptides.International journal of molecular sciences · 2017
    Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Junghee Lim1] ProCell R&D Institute, ProCell Therapeutics, Inc., Ace-Twin Tower II, Guro3-dong, Guro-gu, Seoul 152-790, Korea [2].
Junghee Kim1] ProCell R&D Institute, ProCell Therapeutics, Inc., Ace-Twin Tower II, Guro3-dong, Guro-gu, Seoul 152-790, Korea [2].
Jinsun KangProCell R&D Institute, ProCell Therapeutics, Inc., Ace-Twin Tower II, Guro3-dong, Guro-gu, Seoul 152-790, Korea.
Daewoong Jo1] ProCell R&D Institute, ProCell Therapeutics, Inc., Ace-Twin Tower II, Guro3-dong, Guro-gu, Seoul 152-790, Korea [2] Department of Biomedical Sciences, Chonnam National University Medical School, 5 Hak-dong, Dong-gu, Kwangju 501-757, Korea [3] Departments of Surgery, Vanderbilt University School of Medicine, 2215B Garland Avenue, Nashville, TN 37232, USA.
Chonnam National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The production of pluripotent stem cells (iPSCs) for therapeutic applications will require practical methods to achieve tight temporal and quantitative control of reprogramming factor (RF) expression, while avoiding the mutagenic potential of gene transfer. Toward this end, we have developed cell-permeable RF proteins (CP-RFs) incorporating newly developed macromolecule transduction domains (MTDs). Treatment of human dermal fibroblasts (HDFs) with combinations of cell-permeable OCT4, SOX2, KLF4, CMYC and either NANOG or LIN28 proteins induced the outgrowth of stem cell-like colonies (iSCs). iSC colonies generated with CP-RFs resembled embryonic stem cells with regard to morphology, biomarker expression, and extended capacity for self-renewal, but failed to expand as iPSC or ES cell lines. Partial reprogramming appears to be a common response to protein-based delivery of programming factors into somatic cells.

Indexed as

Cellular ReprogrammingCell DifferentiationCell Membrane PermeabilityCell-Penetrating PeptidesCells, CulturedFibroblastsGene ExpressionHomeodomain ProteinsHumansKruppel-Like Factor 4Kruppel-Like Transcription FactorsNanog Homeobox ProteinOctamer Transcription Factor-3Protein Structure, TertiaryProtein TransportProto-Oncogene Proteins c-mycCell-Penetrating PeptidesHomeodomain ProteinsKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsLin28A protein, humanMYC protein, humanNanog Homeobox ProteinNANOG protein, humanOctamer Transcription Factor-3POU5F1 protein, humanProto-Oncogene Proteins c-mycRecombinant Fusion ProteinsRNA-Binding ProteinsSOX2 protein, humanSOXB1 Transcription Factors

Identifiers

PMID24618595
PMCPMC3950638
OpenAlexW2070595925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.